Verrico CD

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Rivastigmine does not alter cocaine-induced subjective effects or self-administration - Patel_2019_Pharmacol.Biochem.Behav__172758
Author(s) : Patel M , Verrico CD , De La Garza R, 2nd
Ref : Pharmacol Biochem Behav , :172758 , 2019
Abstract : Patel_2019_Pharmacol.Biochem.Behav__172758
ESTHER : Patel_2019_Pharmacol.Biochem.Behav__172758
PubMedSearch : Patel_2019_Pharmacol.Biochem.Behav__172758
PubMedID: 31430484

Title : Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder - De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
Author(s) : De La Garza R, 2nd , Verrico CD , Newton TF , Mahoney JJ, 3rd , Thompson-Lake DG
Ref : Int J Neuropsychopharmacol , 19 :pyv098 , 2016
Abstract : De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
ESTHER : De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
PubMedSearch : De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
PubMedID: 26364275

Title : Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers - Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
Author(s) : Mahoney JJ, 3rd , Kalechstein AD , Verrico CD , Arnoudse NM , Shapiro BA , De La Garza R, 2nd
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 50 :137 , 2014
Abstract : Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
ESTHER : Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
PubMedSearch : Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
PubMedID: 24239594

Title : Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers - Verrico_2014_Int.J.Neuropsychopharmacol_17_223
Author(s) : Verrico CD , Mahoney JJ , Thompson-Lake DG , Bennett RS , Newton TF , De La Garza R
Ref : Int J Neuropsychopharmacol , 17 :223 , 2014
Abstract : Verrico_2014_Int.J.Neuropsychopharmacol_17_223
ESTHER : Verrico_2014_Int.J.Neuropsychopharmacol_17_223
PubMedSearch : Verrico_2014_Int.J.Neuropsychopharmacol_17_223
PubMedID: 24393456

Title : Endocannabinoid metabolism in the prefrontal cortex in schizophrenia - Volk_2013_Schizophr.Res_147_53
Author(s) : Volk DW , Siegel BI , Verrico CD , Lewis DA
Ref : Schizophr Res , 147 :53 , 2013
Abstract : Volk_2013_Schizophr.Res_147_53
ESTHER : Volk_2013_Schizophr.Res_147_53
PubMedSearch : Volk_2013_Schizophr.Res_147_53
PubMedID: 23561296

Title : Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects - George_2001_Biol.Psychiatry_49_300
Author(s) : George TP , Picciotto MR , Verrico CD , Roth RH
Ref : Biological Psychiatry , 49 :300 , 2001
Abstract : George_2001_Biol.Psychiatry_49_300
ESTHER : George_2001_Biol.Psychiatry_49_300
PubMedSearch : George_2001_Biol.Psychiatry_49_300
PubMedID: 11230881

Title : Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization - George_2000_J.Pharmacol.Exp.Ther_295_58
Author(s) : George TP , Verrico CD , Picciotto MR , Roth RH
Ref : Journal of Pharmacology & Experimental Therapeutics , 295 :58 , 2000
Abstract : George_2000_J.Pharmacol.Exp.Ther_295_58
ESTHER : George_2000_J.Pharmacol.Exp.Ther_295_58
PubMedSearch : George_2000_J.Pharmacol.Exp.Ther_295_58
PubMedID: 10991961